Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2007.101683v1, 2008; 10.1373/clinchem.2007.101683
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2007.101683v1
55/1/85    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eggers, K. M.
Right arrow Articles by Lindahl, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eggers, K. M.
Right arrow Articles by Lindahl, B.

Received on December 5, 2007
Accepted on August 19, 2008

General Clinical Chemistry

Value of Cardiac Troponin I Cutoff Concentrations below the 99th Percentile for Clinical Decision-making

Kai M. Eggers 1*, Allan S. Jaffe 2, Lars Lind 3, Per Venge 4, Bertil Lindahl 5

1 Department of Medical Sciences, Uppsala University Hospital, Sweden
2 Department of Mayo Medical School, Rochester, MN
3 Department of Medicine, Uppsala University Hospital, Sweden
4 Department of Clinical Chemistry, Uppsala University Hospital, Sweden
5 Department of Medical Sciences, Cardiology, Uppsala University Hospital, Sweden

* To whom correspondence should be addressed. E-mail: kai.eggers{at}ucr.uu.se.

BACKGROUND: The aim of this study was to evaluate factors influencing measurement of the 99th percentile for cardiac troponin I (cTnI) when this cutoff value is established on a highly sensitive assay, and to compare the value of this cutoff to that of lower cutoffs in the prognostic assessment of patients with coronary artery disease.

METHODS: We used the recently refined Access AccuTnI assay (Beckman-Coulter) to assess the distribution of cTnI results in a community population of elderly individuals [PIVUS (Prospective Study of the Vasculature in Uppsala Seniors) study; n = 1005]. The utility of predefined cTnI cutoffs for risk stratification was then evaluated in 952 patients from the FRISC II (Fragmin and Fast Revascularization during Instability in Coronary Artery Disease) study at 6 months after these patients had suffered acute coronary syndrome.

RESULTS: Selection of assay results from a subcohort of PIVUS participants without cardiovascular disease resulted in a decrease of the 99th percentile from 0.044 µg/L to 0.028 µg/L. Men had higher rates of cTnI elevation with respect to the tested thresholds. Although the 99th percentile cutoff was not found to be a useful prognostic indicator for 5-year mortality, both the 90th percentile (hazard ratio 3.1; 95% CI 1.9–5.1) and the 75th percentile (hazard ratio 2.8; 95% CI 1.7–4.7) provided useful prognostic information. Sex-specific cutoffs did not improve risk prediction.

CONCLUSIONS: The 99th percentile of cTnI depends highly on the characteristics of the reference population from which it is determined. This dependence on the reference population may affect the appropriateness of clinical conclusions based on this threshold. However, cTnI cutoffs below the 99th percentile seem to provide better prognostic discrimination in stabilized acute–coronary-syndrome patients and therefore may be preferable for risk stratification.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
P. A. Kavsak, X. Wang, D. T. Ko, A. R. MacRae, and A. S. Jaffe
Short- and Long-Term Risk Stratification Using a Next-Generation, High-Sensitivity Research Cardiac Troponin I (hs-cTnI) Assay in an Emergency Department Chest Pain Population
Clin. Chem., October 1, 2009; 55(10): 1809 - 1815.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. Keller, T. Zeller, D. Peetz, S. Tzikas, A. Roth, E. Czyz, C. Bickel, S. Baldus, A. Warnholtz, M. Frohlich, et al.
Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction
N. Engl. J. Med., August 27, 2009; 361(9): 868 - 877.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. O. Collinson, O. Clifford-Mobley, D. Gaze, F. Boa, and R. Senior
Assay Imprecision and 99th-Percentile Reference Value of a High-Sensitivity Cardiac Troponin I Assay
Clin. Chem., July 1, 2009; 55(7): 1433 - 1434.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
F. S. Apple
A New Season for Cardiac Troponin Assays: It's Time to Keep a Scorecard
Clin. Chem., July 1, 2009; 55(7): 1303 - 1306.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American Association for Clinical Chemistry.